Your browser doesn't support javascript.
loading
Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma.
Schlumberger, M; Elisei, R; Müller, S; Schöffski, P; Brose, M; Shah, M; Licitra, L; Krajewska, J; Kreissl, M C; Niederle, B; Cohen, E E W; Wirth, L; Ali, H; Clary, D O; Yaron, Y; Mangeshkar, M; Ball, D; Nelkin, B; Sherman, S.
Afiliação
  • Schlumberger M; Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy and University Paris-Saclay, Villejuif, France. Electronic address: martin.schlumberger@gustaveroussy.fr.
  • Elisei R; Endocrine Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Müller S; Department of Nuclear Medicine, University Hospital Essen, Essen, Germany.
  • Schöffski P; Department of General Medical Oncology, KU Leuven, Leuven; Laboratory of Experimental Oncology at the University Hospitals Leuven, KU Leuven, Leuven, Belgium.
  • Brose M; Department of Otorhinolaryngology: Head and Neck Surgery, Abramson Cancer Center of the University of Pennsylvania, Philadelphia.
  • Shah M; Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, USA.
  • Licitra L; IRCCS Foundation, National Cancer Institute, Milan; University of Milan, Milan, Italy.
  • Krajewska J; Maria Sklodowska-Curie Memorial Institute - Cancer Center Gliwice Branch, Gliwice, Poland.
  • Kreissl MC; Department of Radiology and Nuclear Medicine, University Hospital Magdeburg, Magdeburg, Germany.
  • Niederle B; Division of Surgical Endocrinology, Medical University of Vienna, Vienna, Austria.
  • Cohen EEW; University of California San Diego Moores Cancer Center, La Jolla.
  • Wirth L; Department of Hematology/Oncology, Massachusetts General Hospital, Boston.
  • Ali H; Henry Ford Health System, Detroit.
  • Clary DO; Exelixis, Inc, South San Francisco.
  • Yaron Y; Exelixis, Inc, South San Francisco.
  • Mangeshkar M; Exelixis, Inc, South San Francisco.
  • Ball D; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore.
  • Nelkin B; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore.
  • Sherman S; Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, USA.
Ann Oncol ; 28(11): 2813-2819, 2017 Nov 01.
Article em En | MEDLINE | ID: mdl-29045520
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridinas / Neoplasias da Glândula Tireoide / Diagnóstico por Imagem / Carcinoma Medular / Anilidas Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridinas / Neoplasias da Glândula Tireoide / Diagnóstico por Imagem / Carcinoma Medular / Anilidas Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article